Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06656182
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-23
Brief Title:
Effect of SNAGs and Scapular Mobilizations in Patients With Scapulocostal Syndrome
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effect of SNAGs and Scapular Mobilizations in Patients With Scapulocostal Syndrome
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine the impact of SNAGs and Scapular mobilizations on pain cervical and shoulder Range of motion and functional outcomes in individuals with Scapulocostal Syndrome
Detailed Description:
The rationale for employing SNAGS Sustained Natural Apophyseal Glides in treating scapulocostal syndrome is multifaceted By targeting specific joint surfaces and soft tissue structures SNAGS aim to address joint dysfunction alleviate pain and improve mobility in the scapulothoracic region These sustained gliding movements not only modulate pain signals but also promote relaxation and reduce muscle tension thereby enhancing the effectiveness of therapeutic exercises aimed at strengthening the surrounding musculature Additionally SNAGS facilitate proper muscle activation patterns optimizing muscle function and coordination Their adaptability allows for a patient-centered approach ensuring tailored treatment that considers individual symptoms mobility deficits and treatment goals ultimately promoting better functional outcomes in individuals with scapulocostal syndrome
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None